Please login to the form below

Not currently logged in
Email:
Password:

ADA 2013

This page shows the latest ADA 2013 news and features for those working in and with pharma, biotech and healthcare.

ADA: Boehringer/ Lilly's empagliflozin shows blood glucose benefits

ADA: Boehringer/ Lilly's empagliflozin shows blood glucose benefits

When taken together, the trials, which were presented over the weekend at the American Diabetes Association's (ADA) Scientific Sessions in Chicago, showed “a very consistent efficacy profile of the drug ... in full at next year's ADA meeting.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics